HIV: Infection control issues for oral healthcare personnel

Journal of Contemporary Dental Practice

Volumn 8, Issue 3, 2007, Pages

  Huber, Michaell A ^a   Terezhalmy, Geza T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

AIDS; Exposure control; HIV infection; HIV prevention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DENTAL CARE; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MOUTH DISEASE; NEEDLESTICK INJURY; PREVALENCE; REVIEW; RISK MANAGEMENT;

ANTI-HIV AGENTS; DENTAL CARE FOR CHRONICALLY ILL; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HIV INFECTIONS; HUMANS; INFECTION CONTROL, DENTAL; MOUTH DISEASES; NEEDLESTICK INJURIES; PREVALENCE; RISK MANAGEMENT;

EID: 33947153776     PISSN: None     EISSN: 15263711     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Centers for Disease Control and Prevention. Pneumocystis pneumonia - Los Angeles. MMWR 1981;30:250-2.
2. Sepkowitz KA. AIDS - the first 20 years. N Engl J Med 2001;344:1764-72.
3. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-35.
4. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Ann Rev Immunol 1995;13:487-512.
5. Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992;41(No. RR-17):1-19.
6. WHO/EURO Report of the Technical Consultation on Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance. Available at: http://www.euro.who.int/document/E87956.pdf (accessed April 7, 2006).
7. Steinbrook R. The AIDS epidemic in 2004. N Engl J Med 2004;351:115-7.
8. Centers for Disease Control and Prevention. Surveillance of healthcare personnel with HIV/AIDS, as of December 2002. Available at: http://www.cdc.gov/ ncidod/dhqp/bp_hiv_hp_with.html (accessed April 4, 2006).
9. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;24:86-96.
10. Sepkowitz KA, Eisenberg L. Occupational deaths among healthcare workers. Emerg Infect Dis 2005;11:1003-8.
11. UNAIDS/WHO working group on global HIV / AIDS and STI surveillance. Guidelines for measuring national HIV prevalence in population-based surveys. Available at: http://www.who.int/hiv/pub/surveillance/ guidelinesmeasuringpopulation.pdf (accessed April 4, 2006).
12. UNAIDS/WHO. AIDS epidemic update December 2005. Available at: http://www.who.int/hiv/epi-update2005_en.pdf (accessed April 11, 2006).
13. Centers for Disease Control and Prevention. Trends in HIV/AIDS diagnosis - 33 states, 2001-2004. MMWR 2005;54:1149-53.
14. Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, Raffi F, Antunes F, von Overbeck J, Lüthy R, Glauser M, Hawkins D, Baumberger C, Yerly S, Perneger TV, Perrin L. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
15. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. MMWR 2001;50(No. RR-19):1-110.
16. Freedberg KA, Samet JH. Think HIV. Why physicians should lower their threshold for HIV testing. Arch Intern Med 1999;159:1994-2000.
17. Food and Drug Administration. Donor screening assays for infectious agents and HIV diagnostic assays. Available at: http://www.fda.gov/cber/ products/testkits.htm (accessed April 10, 2006).
18. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, Ashby R, O'Dowd JO, McPherson T, Stalzer B, Hightow L, Miller WC, Eron JJ Jr, Cohen MS, Leone PA. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352;1873-83.
19. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005;352:570-85.
20. Hammer SM. Management of newly diagnosed HIV infection. N Engl J Med 2005;353:1702-10.
21. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl Med 2005;352:586-95.
22. Panel on Clinical Practices for the Treatment of HIV Infection, October 6, 2005, http://AIDSinfo.nih.gov. Accessed on may 1, 2006.
23. EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993;22:289-91.
24. Ramírez-Amador V, Ponce-De-León S, Sierra-Madero J, Soto-Ramírez L, Esquivel-Pedraza L, Anaya-Saavedra G. Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients. AIDS Res Hum Retroviruses 2005;21:981-90.
25. Vaseliu N, Carter AB, Kline NE, Kozinetz C, Cron SG, Matusa R, Kline MW. Longitudinal study of the prevalence and prognostic implications of oral manifestations in Romanian children infected with human immunodeficiency virus type 1. Pediatr Infect Dis 2005;24:1067-71.
26. Challacombe SJ, Coogan MM, Williams DM. Overview of the fourth international workshop on the oral manifestations of HIV infection. Oral Dis 2002;8(Suppl 2):9-14.
27. Kademani D, Glick M. Oral ulcerations in individuals infected with human immunodeficiency virus: Clinical presentations, diagnosis, management, and relevance to disease progression. Quintessence Int 1998;29:523-34.
28. Rohrmus B, Thoma-Greber EM, Bogner JR, Röcken M. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 2000;356:2160.
29. Patton LL, Phelan JA, Ramirez-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Dis 2002;8(Suppl 2):98-109.
30. Miziara ID, Filho BC, Weber R. Oral lesions in Brazilian HIV-infected children undergoing HAART. Int J Pediatr Otorhinolaryngol 2006 Jan 4; [Epub ahead of print].
31. Lawn SD, Checkley A, Wansbrough-Jones MH. Acute bilateral parotitis caused by Mycobacterium scrofulaceum: immune reconstitution disease in a patient with AIDS. Sex Transm Inf 2005;81:517-8.
32. Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Cur Opin Infect Dis 2006;19:20-25.
33. Reznik DA. Oral manifestations of HIV disease. Top HIV Med 2005;13:143-8.
34. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167-70.
35. Crossley ML. An investigation of dentists' knowledge, attitudes and practices towards HIV+ and patients with other blood-borne viruses in South Cheshire, UK. Br Dent J 2004;196:749-54.
36. Shirlaw PJ, Chikte U, Schmidt-Westhausen A, Croser D, Reichart P. Oral and dental care and treatment protocols for the management of HIV-infected patients. Oral Dis 2002;8(Suppl 2):136-43.
37. DePaola LG. Managing the care of patients infected with bloodborne diseases. J Am Dent Assoc 2003;134:1350-8.
38. Campo-Trampero J, Cano-Sánchez J, del Romero-Guerroro J, Moreno-López LA, Cerero-Lapiedra R, Bascones-Martínez A. Dental management of patients with human immunodeficiency virus. Quintessence Int 2003;34:515-25.
39. Puls RL, Emery S. Therapeutic vaccination against HIV: current progress and future possibilities. Clin Sci (London);2006;110:59-71.
40. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485-1490.
41. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR 2005;54(No. RR-9):1-24.
42. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997;102(suppl 5B):9-15.
43. Ippolito G, Puro V, De Carli G, Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus in health care workers. Arch Int Med 1993;153:1451-1458.
44. Centers for Disease Control and Prevention. Update: human immunodeficiency virus infection in healthcare workers exposed to blood of infected patients. MMWR 1987;36:285-289.
45. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-153.
46. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, Lane HC, Fedio J, Saah AJ. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann Intern Med 1990;113:740-746.
47. Centers for Disease Control and Prevention. Guidelines for infection control in dental health-care settings-2003. MMWR 2003;52(No. RR-17):1-68.
48. Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne pathogens; final rule. Federal Register 1991;56:64004-64182.
49. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50 (No. RR-11):1-51.
50. Jochimsen EM. Failure of zidovudine postexposure prophylaxis. Am J Med 1997;102(suppl 5B):52-55.
51. Hawkins DA, Asboe D, Barlow K, Evans B. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis. J Infect 2001;43:12-18.
52. Ciesielski C, Marianos D, Ou CY, Dumbaugh R, Witte J, Berkelman R, Gooch B, Myers G, Luo CC, Schochetman G. Transmission of human immunodeficiency virus in a dental practice. Ann In tern Med 1992;116:798-805.
53. Centers for Disease Control and Prevention. Investigations of patients who have been treated by HIV-infected health-care workers - United States. MMWR 1993;42:329-331, 337.
54. Robert LM, Chamberland ME, Cleveland JL, Marcus R, Gooch BF, Srivastava PU, Culver DH, Jaffe HW, Marianos DW, Panlilio AL, Bell DM. Investigation of patients of health care workers infected with HIV: the Centers for Disease Control and Prevention database. Ann Intern Med 1995;40(No, RR-8).
55. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, and Deitchman SD. Guideline for infection control in health care personnel, 1998. Am J Infect Cont 1998;26:289-354.